Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Italian Trigeminal Autonomic Cephalalgias Assessment Study (ITACA)

NCT07812740 is registered in ClinicalTrials.gov with Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta as lead sponsor.

NCT NCT07812740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07812740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Italian Trigeminal Autonomic Cephalalgias Assessment Study (ITACA)
Lead sponsor
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Phase
Observational
Overall status
Recruiting
Start date
September 15, 2026
Completion date
June 30, 2032
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cluster headache, hemicrania continua, paroxysmal hemicrania, short lasting unilateral neuralgiform headache attacks, sunct, trigeminal autonomic cephalalgias